In multivariable analysis, six clinicopathologic variables were significantly associated with time to recurrence: ulceration, tumor thickness, tumor location, neurotropism (tumor growth along nerves), ...
Several clinicopathologic features beyond tumor thickness and ulceration are associated with recurrence risk in patients with localized stage I-II melanoma.
FRIENDSWOOD, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to ...
A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for identifying recurrence risks in patients with early-stage melanoma who do not ...
Oncology-focused biotech company SkylineDx said an independent study shows that Merlin CP-GEP, the company’s test for treatment decisions in early-stage melanoma, correctly categorizes patients with ...
Melanoma is one of the most dangerous forms of skin cancer, and spotting it early can make all the difference. While most people keep an eye on suspicious moles, many subtle early melanoma signs often ...
The Initiative helps clinicians align their clinical practice with updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Melanoma (Version 1.2026) frameworkProvides T1b and ...
DES MOINES, Iowa — State lawmakers received a progress update on the $1 million state-funded study investigating the high cancer rate in Iowa. Last session, legislators allocated $1 million dollars to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results